PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27553015-8	2017	Moreover, TNF-alpha and IL-6 levels were significantly decreased in cortex and hippocampus of parthenolide-treated rats.	parthenolide	94-106	interleukin 6	Rattus norvegicus	24-28	
22004922-4	2011	The initial hypothermia was exaggerated; the second phase of the biphasic LPS-induced fever and circulating interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFalpha) were significantly attenuated only in parthenolide-pretreated animals.	parthenolide	210-222	interleukin 6	Rattus norvegicus	108-121	
22004922-8	2011	In summary, pretreatment with parthenolide attenuates the febrile response during LPS-induced systemic inflammation by reducing circulating IL-6 and TNFalpha and decreasing hypothalamic NFkappaB/NF-IL6 activation, oxidative stress and expression of COX2.	parthenolide	30-42	interleukin 6	Rattus norvegicus	140-144	
20605167-6	2011	RESULTS: Both parthenolide and resveratrol treatment led to early significant increases in plasma levels of IL-6.	parthenolide	14-26	interleukin 6	Rattus norvegicus	108-112	
21223972-10	2011	Moreover, parthenolide attenuated the Ang II-induced expression of interleukin-6, a potent pro-hypertrophic fibroblast-derived factor.	parthenolide	10-22	interleukin 6	Rattus norvegicus	67-80